Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

1,002 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Completed

Pembro/Carbo/Taxol in Endometrial Cancer

NCT02549209

Conditions
Endometrial Adenocarcinoma, Endometrial Cancer, Endometrial Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers Mesa, Arizona, United States
  • Northwestern University, Robert H. Lurie Cancer Center Chicago, Illinois, United States
  • Northwestern Medicine Lake Forest Hospital Lake Forest, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View Trial Details
Completed

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

NCT00101972

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +80 more
Locations
  • Premiere Oncology Santa Monica, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

NCT02001623

Conditions
Adnexal Diseases, Bladder Cancer, Carcinoma, +46 more
Locations
  • University of California Irvine Medical Center (UCIMC) Orange, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • University Gynecologic Oncology Atlanta, Georgia, United States
View all 29 locations
View Trial Details
Completed

A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer

NCT02725268

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of Arizona Cancer Center Phoenix, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
View all 78 locations
View Trial Details

Related conditions